Affimed (NASDAQ:AFMD) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. HC Wainwright restated a buy rating and issued a $5.00 price objective on shares […]
More Stories
ChampionX Q3 EPS Estimate Reduced by Capital One Financial
ChampionX Co. (NASDAQ:CHX – Free Report) – Research analysts at Capital One Financial decreased their Q3 2024 EPS estimates for...
Stifel Canada Comments on Kinross Gold Q3 Earnings
Kinross Gold Co. (NYSE:KGC – Free Report) (TSE:K) – Investment analysts at Stifel Canada issued their Q3 2024 earnings estimates...
What is Stifel Canada’s Estimate for TSE:OR Q3 Earnings?
Osisko Gold Royalties Ltd (TSE:OR – Free Report) – Stock analysts at Stifel Canada issued their Q3 2024 earnings per...
Q3 Earnings Forecast for TSE:AEM Issued By Stifel Canada
Agnico Eagle Mines Limited (TSE:AEM – Free Report) (NYSE:AEM) – Research analysts at Stifel Canada issued their Q3 2024 EPS...
Stifel Canada Estimates Calibre Mining Q3 Earnings
Calibre Mining Corp. (TSE:CXB – Free Report) – Equities researchers at Stifel Canada issued their Q3 2024 earnings per share...
Demant A/S (OTCMKTS:WILYY) Upgraded by The Goldman Sachs Group to “Strong-Buy”
Demant A/S (OTCMKTS:WILYY – Get Free Report) was upgraded by stock analysts at The Goldman Sachs Group to a “strong-buy”...